Articles Archive - Bioduro

Let's talk
Contact us

2017.03.29

BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify™

A drug screening platform combining humanized 3D cell culture and patient-derived xenograft models, across a set of 300 proprietary tumor models.

March 2018
BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
March 2018
BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities
January 2018
BioDuro Announces Cooperation Agreement with Porton Pharma Solutions
November 2016
New Strategies Required to Meet Changing Needs in the Analytical Services Market
November 2016
BioDuro Increases Spray Dried Drug Product Manufacturing Capacity
September 2016
BioDuro Completes Infrastructure Expansion in Shanghai
June 2016
BioDuro Launches as Unique Contract Research and Drug Manufacturing Organization
April 2016
Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success
January 2016
BioDuro, LLC Adds Industry Veteran CFO to Executive Team